DrugPatentWatch Database Preview
Drugs in Development Information for Zicronapine
» See Plans and Pricing
What is the drug development status for Zicronapine?
Zicronapine is an investigational drug.
There have been 4 clinical trials for Zicronapine.
The most recent clinical trial was a Phase 3 trial, which was initiated on April 1st 2011.
The most common disease conditions in clinical trials are Schizophrenia and [disabled in preview]. The leading clinical trial sponsors are H. Lundbeck A/S and [disabled in preview].
There are fourteen US patents protecting this investigational drug and two hundred and forty-seven international patents.
Summary for Zicronapine
| US Patents | 14 |
| International Patents | 247 |
| US Patent Applications | 21 |
| WIPO Patent Applications | 89 |
| Japanese Patent Applications | 1 |
| Clinical Trial Progress | Phase 3 (2011-04-01) |
| Vendors | 6 |
Recent Clinical Trials for Zicronapine
| Title | Sponsor | Phase |
|---|---|---|
| Study of the Safety, Tolerability, and Pharmacokinetics of Once Weekly Zicronapine in Patients With Schizophrenia | H. Lundbeck A/S | Phase 2 |
| Safety and Efficacy of Zicronapine in Patients With Schizophrenia | H. Lundbeck A/S | Phase 3 |
| Efficacy of Lu 31-130 in Patients With Schizophrenia | H. Lundbeck A/S | Phase 2 |
Clinical Trial Summary for Zicronapine
Top disease conditions for Zicronapine
Top clinical trial sponsors for Zicronapine
US Patents for Zicronapine
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| Zicronapine | Start Trial | Deuterated 1-piperazino-3-phenyl indanes for treatment of schizophrenia | H. LUNDBECK A/S (Valby, DK) | Start Trial |
| Zicronapine | Start Trial | Crystalline base of trans-1-((1R,3S)-6-chloro-3-phenylindan-1-yl)-3,3-dimethylpiperazine | H. Lundbeck A/S (Valby-Copenhagen, DK) | Start Trial |
| Zicronapine | Start Trial | Hydrogen succinate salts of trans-4-((1R, 3S)-6-chloro-3-phenylindan-1-YL)-1,2,2-trimethylpiperazine and the use as a medicament | H. Lundbeck A/S (Valby-Copenhagen, DK) | Start Trial |
| Zicronapine | Start Trial | Trans-1(6-chloro-3-phenylindan-1-yl)-3,3-dimethylpiperazine | H. Lundbeck A/S (Valby-Copenhagen, DK) | Start Trial |
| Zicronapine | Start Trial | Malonate salt of 4-((1R,3S)-6-chloro-3-phenylindan-1-yl)-1,2,2-trimethylpiperazine and uses of same | Start Trial | |
| Zicronapine | Start Trial | Processes for 4-((1R,35)-6-Chloro-3-phenylindan-1-yl)-1,2,2-trimethylpiperazine or a salt thereof | H. Lundbeck A/S (Valby, DK) | Start Trial |
| Zicronapine | Start Trial | Crystalline base of trans-1-((1R,3S)-6-chloro-3-phenylindan-1-yl)-3,3-dimethylpiperazine | H. Lunbeck A/S (Valby, DK) | Start Trial |
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for Zicronapine
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| Zicronapine | African Regional IP Organization (ARIPO) | AP3310 | 2031-06-20 | Start Trial |
| Zicronapine | Argentina | AR086987 | 2031-06-20 | Start Trial |
| Zicronapine | Australia | AU2012273657 | 2031-06-20 | Start Trial |
| Zicronapine | Brazil | BR112013031702 | 2031-06-20 | Start Trial |
| Zicronapine | Canada | CA2837820 | 2031-06-20 | Start Trial |
| Zicronapine | Chile | CL2013003646 | 2031-06-20 | Start Trial |
| Zicronapine | China | CN103649019 | 2031-06-20 | Start Trial |
| >Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |
